Effect of tellurite on growth of extensively drug resistant (XDR) Mycobacterium tuberculosis and action on mycobacterial drug efflux pump

Effect of tellurite on growth of extensively drug resistant (XDR) Mycobacterium tuberculosis and action on mycobacterial drug efflux pump

In the present study genotypic resistance of bacterial strain to first- and second-line anti-tuberculosis drugs was determined by Line probe assay. Toxic effect of tellurite on the growth of Mycobacterium tuberculosis (MTB) was determined by growing cells in different concentrations of tellurite (1...

Full description

Bibliographic Details
Main Authors:	Saba Kabir, Hasan Ejaz, Syed Zajif Hussain, Muhammad Asif Rasheed, Kashaf Junaid, Abdul Rehman
Format:	Article
Language:	English
Published:	Elsevier 2023-05-01
Series:	Journal of King Saud University: Science
Subjects:	Tellurite XDR-TB mmpL7 gene Drug efflux pump
Online Access:	http://www.sciencedirect.com/science/article/pii/S1018364723000915

Similar Items

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
by: Ketaki V Utpat, et al.
Published: (2023-01-01)

Mechanistic and Structural Insights Into the Unique TetR-Dependent Regulation of a Drug Efflux Pump in Mycobacterium abscessus
by: Matthias Richard, et al.
Published: (2018-04-01)

Alternate efflux pump mechanism may contribute to drug resistance in extensively drug-resistant isolates of Mycobacterium tuberculosis
by: Akbar Kanji, et al.
Published: (2016-01-01)

Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps
by: Hasan Ghajavand, et al.
Published: (2019-05-01)

Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report
by: Nafiseh Izadi, et al.
Published: (2015-01-01)

MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
by: Wei Li, et al.
Published: (2018-07-01)

Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of <i>Mycobacterium smegmatis</i>: A Combined In Silico and In Vitro Study
by: Mohd Shahbaaz, et al.
Published: (2022-01-01)

The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis
by: Heidary M, et al.
Published: (2019-11-01)

Tuberculosis extremadamente resistente (TB-XDR), historia y situación actual
by: Alberto Mendoza Ticona, et al.
Published: (2018-06-01)

Pre-XDR spinal tuberculosis and 360° approach in two surgical times: a case report
by: C. Montero-Silva, et al.
Published: (2023-01-01)

Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases
by: Isaac Darko Otchere, et al.
Published: (2023-01-01)

Risk Factors for Poor Outcomes Among Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB): A Scoping Review
by: Varshney K, et al.
Published: (2021-12-01)

Predominance of Beijing lineage among pre-extensively drug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis: A tertiary care center experience
by: Syed Beenish Rufai, et al.
Published: (2016-01-01)

Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil
by: Tania Matsui, et al.
Published: (2020-05-01)

Extensively drug resistant tuberculosis in Mali: a case report
by: Bassirou Diarra, et al.
Published: (2017-11-01)

Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China
by: Zhang P, et al.
Published: (2022-05-01)

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
by: Viola Dreyer, et al.
Published: (2022-08-01)

Elastic, Electrical and Thermal Properties of Tellurite Glass Systems
by: Mohamed Kamari, Halimah
Published: (2007)

Kaca oksiklorida berasaskan tellurite /
by: Md. Rahim Sahar, 1957-, et al.
Published: (1999)

MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections
by: Jigar P. Sethiya, et al.
Published: (2020-08-01)

Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94–32 central Asian/Russian clusters
by: B. J. Klotoe, et al.
Published: (2019-06-01)

Flavoprotein-mediated tellurite reduction: structural basis and applications to the synthesis of tellurium-containing nanostructures
by: Mauricio Arenas-Salinas, et al.
Published: (2016-07-01)

Computational analysis of RNA methyltransferase Rv3366 as a potential drug target for combating drug-resistant Mycobacterium tuberculosis
by: Tasmin Nazim, et al.
Published: (2024-01-01)

Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
by: Hoa Binh Nguyen, et al.
Published: (2016-06-01)

Spectroscopic studies of erbium doped zinc tellurite glass embedded with gold nanoparticles /
by: Erna Jaafar, author, et al.
Published: (2014)

Kaca oksiklorida berasaskan tellurite [electronic resource] /
by: Md. Rahim Sahar, 1957-, et al.
Published: (1999)

Evaluation of TBMDR® and XDRA® for the detection of multidrug resistant and pre-extensively drug resistant tuberculosis
by: Eunjin Cho, et al.
Published: (2022-05-01)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
by: Barbara Eker, et al.
Published: (2008-11-01)

Elastic, optical and thermal properties of zinc-lead tellurite glass systems
by: Alazoumi, Salah Hassan Almokhtar
Published: (2018)

Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022-01-01)

Spectroscopic studies of erbium doped zinc tellurite glass embedded with gold nanoparticles [electronic resource] /
by: Erna Jaafar, author, et al.
Published: (2014)

Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
by: Amaylia Oehadian, et al.
Published: (2022-04-01)

High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates
by: Kanwara Trisakul, et al.
Published: (2022-12-01)

Understanding the Phage–Host Interaction Mechanism toward Improving the Efficacy of Current Antibiotics in <i>Mycobacterium abscessus</i>
by: Mylene Gorzynski, et al.
Published: (2023-05-01)

The effect of Yb3+ on corrosion of lead oxychloride tellurite glasses /
by: Muhammad Abdullah Izat Mohd Yassin, 1988-, et al.
Published: (2013)

Drug resistance patterns, treatment outcomes and factors affecting unfavourable treatment outcomes among extensively drug resistant tuberculosis patients in Pakistan; a multicentre record review
by: Muhammad Atif, et al.
Published: (2022-04-01)

Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
by: Jaksuwan R, et al.
Published: (2017-06-01)

Drug-Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001–2007
by: Kristina Wallengren, et al.
Published: (2011-10-01)

A review of clinical profile, complications and antibiotic susceptibility pattern of extensively drug-resistant (XDR) Salmonella Typhi isolates in children in Karachi
by: Saba Shahid, et al.
Published: (2021-09-01)

The Mycobacterium tuberculosis MmpL3 inhibitor MSU-43085 is active in a mouse model of infection
by: John T. Williams, et al.
Published: (2024-01-01)